Truvian Sciences: Ajay Bansal, Tyler Jensen, Joe Benson, Eric Zieger
Truvian Sciences has appointed Ajay Bansal its CFO, Tyler Jensen its chief product officer, Joe Benson its VP of strategy and portfolio management, and Eric Zieger its VP of global sales. Additionally, existing team members Jay Srinivasan was named chief strategy officer and Cofounder Dena Marrinucci was named chief science officer.
Bansal was most recently CFO and head of business development at Urovant Sciences. Jensen was SVP of engineering and product technical support for GenMark Diagnostics, while Benson was head of R&D strategy and operations at Arena Pharmaceuticals. Before that, he led portfolio planning and prioritization efforts in the oncology business unit and clinical genomics division at Illumina.
Zieger was director of strategic and corporate accounts for GenMark. Prior to that, he held sales positions at Roche Tissue Diagnostics.